Monogram Health is a value-based specialty provider of in-home evidence-based care and benefit management services to patients suffering from polychronic conditions such as chronic kidney disease and end-stage renal disease. They use an innovative in-home care delivery model and a technology-driven array of evidence-based clinical services to improve patient outcomes and quality of life while lowering medical costs.

Monogram Health, Inc.

Monogram Health is a leading value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease.

Frist Cressey Ventures

Norwest Venture Partners

Humana

Cigna Ventures

Scan

Heritage Group

Pura Vida Investments

Memorial Hermann Hospital

CVS Health

Monogram Health

During National Nurse Practitioners Week, we extend our heartfelt gratitude to our incredible NPs at Monogram Health. Your compassion, dedication, and commitment to providing evidence-based in-home care make a world of difference in the lives of our patients. Thank you for helping our patients live happier, healthier lives.

Wishing all those who observe, a joyful and prosperous Diwali! May the Festival of Lights fill your life with happiness and illuminate your path.

Today, we honor and express our deepest gratitude to all the brave men and women who have served our country. Your sacrifice and dedication to preserving our freedom are greatly appreciated. Thank you for your service.

#veteransday #veteransday2023

Monogram Health honors Native American Heritage Month. Native Americans make up about 3 percent of the U.S. population, yet they have the highest rate of diabetes and one of the highest rates of end stage kidney disease. We work closely with our Native American patients to change this reality.

At Monogram, we are committed in our mission to help patients with ESKD and CKD live happier, healthier lives.

#nativeamericanheritagemonth

Come meet the Monogram Health team at #ASN booth 1641 for a conversation with some of our employed Nephrologists from across the company.

#ASN #nephrology #physician #Philadelphia #valuebasedcare

November is National Diabetes Month and at Monogram Health we are focused on improving diabetes outcomes. Why? Because over 1 in 3 Americans diagnosed with diabetes will have kidney disease. We provide high-value clinical care, through our in-home polychronic care model, focused on patients with CKD and ESKD. Our dedicated employed Endocrinologists work with local providers to ensure patients can optimally manage their diabetes so that they can slow the progression of their kidney disease. Join us in raising awareness of diabetes and together, we can make a meaningful difference. 

#NationalDiabetesMonth #MonogramHealth

Monogram Health’s CMO Dr. Shaminder Gupta, MD participated in a dynamic panel today at #ASN focused on value-based care and the need to shift #nephrology care models.

Make sure to stop by booth 1641 for the continuation of this robust discussion.

#ASN #nephrology #physician #Philadelphia #valuebasedcare

Our Monogram Health team will be participating at the #ASN2023 meeting in #Philadelphia starting Thursday morning. Stop by Booth 1641 to discuss opportunities to join our employed network of physicians spanning 35 states as we deliver innovative high-value kidney care in the home.

Additionally, this Wednesday afternoon at 4:20 PM, join Monogram Health’s CMO Dr. Shaminder Gupta, MD for an #ASN panel discussion about evolving #nephrology care models. Our next-generation, innovative #kidney care model dramatically improves patient outcomes and quality of life while reducing unnecessary medical cost across the healthcare continuum.

#ASN #nephrology #physician #compassion

Monogram Health is on a mission to transform healthcare for patients with CKD and ESKD. We are reshaping kidney care with innovative clinical models and unique in-home care. The only piece we’re missing is a nurse like you.

Living with kidney disease can be challenging, but by pursuing evidence-based in-home dialysis, Mr. Folse has found a new way to live with little interruption. Clinical research shows that home dialysis leads to improved quality of life when compared to in-center dialysis, unfortunately, many patients are unaware of this treatment option. Patient quality of life is not just about managing a condition but embracing solutions that fit one’s lifestyle. In-home dialysis has given Mr. Folse the freedom and flexibility to design his treatment around his schedule, spend more time with loved ones, and pursue his interests without interruption. His story is a testament to the transformative power of effective in-home healthcare.

msh id	COM:MONOGRAMHEALTH
symbol	-
name	Monogram Health, Inc.
homepage url	https://www.monogramhealth.com/
country	US
sector	Healthcare Services
industry	Healthcare
market	PRIVATE
employee count	498
crunchbase url	https://www.crunchbase.com/organization/monogram-health
linkedin url	https://www.linkedin.com/company/monogram-health
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	52.28
growth score 28	16.07
growth score 90	50.73
growth score 365	30.73

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:MONOGRAMHEALTH

Monogram Health, Inc.

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-